Earnings estimate | Current qtr. (Mar 2023) | Next qtr. (Jun 2023) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 3 | 3 |
Avg. Estimate | 0.87 | 0.9 | 3.66 | 3.94 |
Low estimate | 0.87 | 0.9 | 3.51 | 3.76 |
High estimate | 0.87 | 0.9 | 3.8 | 4.05 |
Year ago EPS | 1.09 | 0.87 | 3.44 | 3.66 |
Revenue estimate | Current qtr. (Mar 2023) | Next qtr. (Jun 2023) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
No. of analysts | 2 | 2 | 3 | 3 |
Avg. Estimate | 8.14B | 8.38B | 35.26B | 37.88B |
Low estimate | 7.95B | 8.23B | 34.46B | 36.86B |
High estimate | 8.32B | 8.53B | 35.88B | 39.54B |
Year ago sales | 13.11B | 8.7B | 36.1B | 35.26B |
Sales growth (year/est) | -37.90% | -3.60% | -2.30% | 7.40% |
Earnings history | 30/03/2022 | 29/06/2022 | 29/09/2022 | 30/12/2022 |
---|---|---|---|---|
Est. EPS | 0.92 | 0.73 | 0.96 | 0.5 |
Actual EPS | 1.09 | 0.87 | 1.1 | 0.6 |
Difference | 0.17 | 0.14 | 0.14 | 0.1 |
Surprise % | 18.50% | 19.20% | 14.60% | 20.00% |
EPS trend | Current qtr. (Mar 2023) | Next qtr. (Jun 2023) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
Current estimate | 0.87 | 0.9 | 3.66 | 3.94 |
7 days ago | 0.87 | 0.9 | 3.66 | 3.94 |
30 days ago | 0.87 | 0.9 | 3.66 | 3.94 |
60 days ago | 0 | 0 | 3.61 | 4 |
90 days ago | 0 | 0 | 3.69 | 4.15 |
EPS revisions | Current qtr. (Mar 2023) | Next qtr. (Jun 2023) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | -20.20% | N/A | N/A | N/A |
Next qtr. | 3.40% | N/A | N/A | N/A |
Current year | 6.40% | N/A | N/A | N/A |
Next year | 7.70% | N/A | N/A | N/A |
Next 5 years (per annum) | 5.30% | N/A | N/A | N/A |
Past 5 years (per annum) | -2.06% | N/A | N/A | N/A |